Spending $400 million to save 30 people a year in a country where more than 48,000 die annually by suicide is a misuse of funds.
Opinion: Where are the guidelines for the production of animals with intentional genomic alterations?
Realizing the benefits of animals with intentional genomic alterations depends on gaining consumers’ trust, which in turn requires a regulatory system that consumers can count on. […]
Mindstrong, once a Silicon Valley darling, is selling off its assets to the therapy platform SonderMind. Former employees told STAT that Mindstrong faced significant pressure from investors to commercialize its… […]
“There was a lot of pressure to commercialize this way too early,” said Mindstrong co-founder Paul Dagum. […]